{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:11Z","timestamp":1786997891757,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.vaccine.2009.05.099","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T05:27:52Z","timestamp":1245648472000},"page":"4953-4960","source":"Crossref","is-referenced-by-count":114,"title":["Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults"],"prefix":"10.1016","volume":"27","author":[{"given":"Ruth A.","family":"Karron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawsar","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Luke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagvanji","family":"Thumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"DiLorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"McAuliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Schappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amorsolo","family":"Suguitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Lamirande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Coelingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kemble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanta","family":"Subbarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March (13)","key":"10.1016\/j.vaccine.2009.05.099_bib1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"issue":"February (13\u201314)","key":"10.1016\/j.vaccine.2009.05.099_bib2","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0264-410X(00)00395-9","article-title":"Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans","volume":"19","author":"Treanor","year":"2001","journal-title":"Vaccine"},{"issue":"May (9523)","key":"10.1016\/j.vaccine.2009.05.099_bib3","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial","volume":"367","author":"Bresson","year":"2006","journal-title":"Lancet"},{"issue":"June (9272)","key":"10.1016\/j.vaccine.2009.05.099_bib4","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2009.05.099_bib5","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.vaccine.2007.02.039","article-title":"Comparison of neutralising antibody assays for detection of antibody to influenza A\/H3N2 viruses: an international collaborative study","volume":"25","author":"Stephenson","year":"2007","journal-title":"Vaccine"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2009.05.099_bib6","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/428948","article-title":"Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a potential priming strategy","volume":"191","author":"Stephenson","year":"2005","journal-title":"J Infect Dis"},{"issue":"August (9587)","key":"10.1016\/j.vaccine.2009.05.099_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2009.05.099_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.coph.2007.06.004","article-title":"Preparing for a possible pandemic: influenza A\/H5N1 vaccine development","volume":"7","author":"Keitel","year":"2007","journal-title":"Curr Opin Pharmacol"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2009.05.099_bib9","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1056\/NEJMoa073121","article-title":"A clinical trial of a whole-virus H5N1 vaccine derived from cell culture","volume":"358","author":"Ehrlich","year":"2008","journal-title":"N Engl J Med"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.05.099_bib10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1086\/590913","article-title":"An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults","volume":"198","author":"Levie","year":"2008","journal-title":"J Infect Dis"},{"issue":"November (50)","key":"10.1016\/j.vaccine.2009.05.099_bib11","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1016\/j.vaccine.2008.08.046","article-title":"Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children","volume":"26","author":"Nolan","year":"2008","journal-title":"Vaccine"},{"issue":"August (33)","key":"10.1016\/j.vaccine.2009.05.099_bib12","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.vaccine.2008.05.077","article-title":"Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults","volume":"26","author":"Nolan","year":"2008","journal-title":"Vaccine"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2009.05.099_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/527489","article-title":"Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults","volume":"197","author":"Bernstein","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.099_bib14","first-page":"19","article-title":"Cross-reactive immunity in adult and elderly patients against clade 2 influenza A H5N1 virus strains induced by Fluval, a reverse genetic-derived adjuvanted H5N1 clade 1 prototype pandemic influenza vaccine","volume":"November (19)","author":"Fazekas","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.05.099_bib15","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/INF.0b013e3181861dd7","article-title":"Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children","volume":"27","author":"Vajo","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2009.05.099_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.05.099_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-3476(00)70097-7","article-title":"Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A\/Sydney) not contained in the vaccine","volume":"136","author":"Belshe","year":"2000","journal-title":"J Pediatr"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2009.05.099_bib18","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.vaccine.2007.02.060","article-title":"Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004","volume":"25","author":"Halloran","year":"2007","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.05.099_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/INF.0b013e31806166f8","article-title":"Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia","volume":"26","author":"Tam","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2009.05.099_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.282.2.137","article-title":"Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial","volume":"282","author":"Nichol","year":"1999","journal-title":"JAMA"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.05.099_bib21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/01.inf.0000143643.44463.b1","article-title":"Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an A\/Fujian\/411\/2002-like H3N2 antigenic variant strain","volume":"23","author":"Mendelman","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"October (27\u201330)","key":"10.1016\/j.vaccine.2009.05.099_bib22","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1016\/S0264-410X(03)00430-4","article-title":"Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate","volume":"21","author":"Chen","year":"2003","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.05.099_bib23","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1371\/journal.pmed.0030360","article-title":"Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets","volume":"3","author":"Suguitan","year":"2006","journal-title":"PLoS Med"},{"issue":"June","key":"10.1016\/j.vaccine.2009.05.099_bib24","article-title":"A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets","author":"Joseph","year":"2008","journal-title":"Virology"},{"issue":"Mar (5)","key":"10.1016\/j.vaccine.2009.05.099_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/596558","article-title":"A live attenuated H9N2 influenza vaccine is well-tolerated and immunogenic in healthy adults","volume":"199","author":"Karron","year":"2009","journal-title":"J Infect Dis"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2009.05.099_bib26","first-page":"261","article-title":"Update on avian influenza A (H5N1) virus infection in humans","volume":"358","author":"Abdel-Ghafar","year":"2008","journal-title":"N Engl J Med"},{"issue":"July (1\u20132)","key":"10.1016\/j.vaccine.2009.05.099_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2004.02.019","article-title":"Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A\/Duck\/Singapore\/97 vaccine","volume":"103","author":"Stephenson","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2009.05.099_bib28","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1128\/IAI.40.3.1044-1051.1983","article-title":"Dose response of A\/Alaska\/6\/77 (H3N2) cold adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus","volume":"40","author":"Clements","year":"1983","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.05.099_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/JVI.01957-06","article-title":"Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines","volume":"81","author":"Sasaki","year":"2007","journal-title":"J Virol"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2009.05.099_bib30","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.0801367105","article-title":"Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies","volume":"105","author":"Kashyap","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7083","key":"10.1016\/j.vaccine.2009.05.099_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/440435a","article-title":"Avian flu: Influenza virus receptors in the human airway","volume":"440","author":"Shinya","year":"2006","journal-title":"Nature"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.05.099_bib32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/CDLI.3.5.511-516.1996","article-title":"Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults","volume":"3","author":"Powers","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.05.099_bib33","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1371\/journal.pmed.0040091","article-title":"Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?","volume":"4","author":"Gillim-Ross","year":"2007","journal-title":"PLoS Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.05.099_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/JVI.2.4.281-288.1968","article-title":"Antiviral activity of antiserum specific for an influenza virus neuraminidase","volume":"2","author":"Kilbourne","year":"1968","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.05.099_bib35","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"Murphy","year":"1972","journal-title":"N Engl J Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.05.099_bib36","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med"},{"issue":"August (32)","key":"10.1016\/j.vaccine.2009.05.099_bib37","doi-asserted-by":"crossref","first-page":"12121","DOI":"10.1073\/pnas.0605134103","article-title":"Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model","volume":"103","author":"Maines","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.05.099_bib38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.inf.0000066244.31769.83","article-title":"A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants","volume":"22","author":"Karron","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.099_bib39","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1086\/315859","article-title":"Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy","volume":"182","author":"Wright","year":"2000","journal-title":"J Infect Dis"},{"issue":"June (28)","key":"10.1016\/j.vaccine.2009.05.099_bib40","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1016\/j.vaccine.2009.03.082","article-title":"A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults","volume":"27","author":"Talaat","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T18:44:41Z","timestamp":1589913881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09008573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":40,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0264410X09008573"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.05.099","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}